Anionic antimicrobial peptide-lysozyme interactions in innate pulmonary immunity

International Journal of Antimicrobial Agents

Volumn 13, Issue 1, 1999, Pages 47-51

  Kalfa, V C ^a   Brogden, K A ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Anionic peptides; Antimicrobial peptides; Bactericidal; Interactions; Lysozyme; Respiratory tract

Indexed keywords

ANION; ANTIINFECTIVE AGENT; LEUKOCYTE ENZYME; LYSOZYME; PEPTIDE; SODIUM CHLORIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNITY; MANNHEIMIA HAEMOLYTICA; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM;

AMINO ACID SEQUENCE; ANIONS; ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; LUNG; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; MICROCOCCUS; MURAMIDASE; PEPTIDES; PSEUDOMONAS AERUGINOSA;

EID: 0032849146     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00095-3     Document Type: Article

References (27)

1. Ellison III R.T., Boose D., LaForce F.M. Isolation of an antibacterial peptide from human lung lavage fluid. J. Infect. Dis. 151:1985;1123-1129.
2. Smith J.J., Travis S.M., Greenberg E.P., Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:1996;229-236.
3. Brogden K.A., DeLucca A.J., Bland J., Elliott S. Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica. Proc. Natl. Acad. Sci. USA. 93:1996;412-416.
4. Brogden K.A., Ackermann M., Huttner K.M. Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium. Infect. Immun. 66:1998;5948-5954.
5. Goldman M.J., Anderson G.M., Stolzenberg E.D., Kari U.P., Zasloff M., Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell. 88:1997;553-560.
6. McCray P.B. Jr., Bentley L. Human airway epithelia express a β-defensin. Am. J. Respir. Cell Mol. Biol. 16:1997;343-349.
7. Bals R., Wang X.R., Wu Z.R. et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102:1998;874-880.
8. Schnapp D., Harris A. Antibacterial peptides in bronchoalveolar lavage fluid. Am. J. Respir. Cell Mol. Biol. 19:1998;352-356.
9. Kaser M.R., Skouteris G.G. Inhibition of bacterial growth by synthetic SP-B1-78 peptides. Peptides. 18:1997;1441-1444.
10. Arima H., Ibrahim H.R., Kinoshita T., Kato A. Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C-terminal using genetic modification. FEBS Lett. 415:1997;114-118.
11. Hiemstra P.S., Maassen R.J., Stolk J., Heinzel-Wieland R., Steffens G.J., Dijkman J.H. Antibacterial activity of antileukoprotease. Infect. Immun. 64:1996;4520-4524.
12. Tomita M., Takase M., Wakabayashi H., Bellamy W. Antimicrobial peptides of lactoferrin. Adv. Exp. Med. Biol. 357:1994;209-218.
13. Antonyraj K.J., Karunakaran T., Raj P.A. Bactericidal activity and poly-L-proline II conformation of the tandem repeat sequence of human salivary mucin glycoprotein (MG2). Arch. Biochem. Biophys. 356:1998;197-206.
14. Raj P.A., Marcus E., Sukumaran D.K. Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. Biopolymers. 45:1998;51-67.
15. Bals R., Wang X.R., Zasloff M., Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Nat. Acad. Sci. USA. 95:1998;9541-9546.
16. Brogden K.A., Ackermann M., Huttner K.M. Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial. Antimicrob. Agents Chem. 41:1997;1615-1617.
17. Strominger J.L., Ghuysen J.M. Mechanisms of enzymatic bacteriolysis. Science. 156:1967;213-221.
18. Boekelheide K., Patt S.L., Weisz G., Baldo J.H., Sykes B.D. Lysozyme catalysis: kinetics of the hydrolysis of cell wall oligosaccharides. Can. J. Biochem. 57:1979;785-788.
19. Jolles P. A possible physiological function of lysozyme. Biomedicine. 25:1976;275-276.
20. Lehrer R.I., Ganz T., Szklarek D., Selsted M.E. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Invest. 81:1988;1829-1835.
21. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:1995;61-92.
22. LaForce F.M., Boose D.S. Effect of zinc and phosphate on an antibacterial peptide isolated from lung lavage. Infect. Immun. 45:1984;692-696.
23. Selsted M.E., Brown D.M., DeLange R.J., Harwig S.S., Lehrer R.I. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J. Biol. Chem. 260:1985;4579-4584.
24. Selsted M.E., Harwig S.S., Ganz T., Schilling J.W., Lehrer R.I. Primary structures of three human neutrophil defensins. J. Clin. Invest. 76:1985;1436-1439.
25. Hodinka R.L., Modrzakowski M.C. Bactericidal activity of granule contents from rat polymorphonuclear leukocytes. Infect. Immun. 40:1983;139-146.
26. Gilljam H., Ellin A., Strandvik B. Increased bronchial chloride concentration in cystic fibrosis. Scand. J. Clin. Lab. Invest. 49:1989;121-124.
27. Joris L., Dab I., Quinton P.M. Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148:1993;1633-1637.